Humacyte
Price & Volume
Stats
See moreOpen | $1.13 |
Previous Close | $1.13 |
Day Range | $1.06-$1.14 |
52W Range | $1.04-$5.66 |
Market Cap | $200.3M |
Shares Short | 34M |
Financials
See moreRevenue (12 Mos) | $1.5M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$73.8M |
Diluted EPS | -$0.27 |
News
See moreYahoo Finance • 2 days ago
Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair
Yahoo Finance • 8 days ago
Humacyte announces credit facility of $77.5M with Avenue Capital
Yahoo Finance • last month
Humacyte outlines 12-month cash runway and accelerates Symvess adoption following $56.5M capital raise
Yahoo Finance • last month
Strong Earnings and Biotech Resilience Define the Midweek Momentum
About
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
CFO | Mr. Dale A. Sander |
Address | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |
